2026-01-20 - Analysis Report
**1. Company Overview**
Newmont is a leading gold mining company that operates globally with a strong portfolio of assets.

**2. Return Rate Comparison**

| Ticker | Cumulative Return |
| --- | --- |
| NEM | 104.37% |
| VOO | 93.30% |

Divergence between NEM and VOO is 11.07%, indicating that the performance of NEM has been slightly better than VOO. 

**3. Alpha, Beta Analysis**

| Period | CAGR | MDD | Alpha | Beta | Cap (B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | -8.0% | 17.2% | -13.0% | 0.1 | 38.1B |
| 2017-2019 | -2.0% | 17.2% | -20.0% | 0.1 | 47.7B |
| 2018-2020 | 10.0% | 19.1% | -11.0% | 0.3 | 65.8B |
| 2019-2021 | 41.0% | 23.5% | -2.0% | 0.3 | 68.1B |
| 2020-2022 | -13.0% | 36.9% | -11.0% | 0.4 | 51.9B |
| 2021-2023 | -25.0% | 36.9% | -26.0% | 0.5 | 45.5B |
| 2022-2024 | -54.0% | 40.6% | -73.0% | 0.5 | 40.9B |
| 2023-2025 | 67.0% | 31.0% | 5.0% | 0.6 | 109.7B |

The Alpha (0.3-0.5) represents average to above-average returns of NEM for the respective periods, indicating a relatively strong performance compared to the market (VOO). Beta (0.1-0.6) suggests that NEM's stock movement is relatively more predictable and less volatile compared to VOO.

**4. Recent Stock Price Fluctuations**

|  Indicator | Value |
| --- | --- |
| Close | $114.12 |
| 5-day SMA | $114.02 |
| 20-day SMA | $106.54 |
| 60-day SMA | $94.22 |
| Last market change | -0.08% |

The recent decline in the closing price and 5-day SMA is a slight sign of downturn. 

**5. RSI, PPO, Delta_Previous_Relative_Divergence, Expected_Return**

| Indicator | Value |
| --- | --- |
| Market Risk Indicator (MRI) | 0.80 |
| RSI | 63.88 |
| PPO | 0.39 |
| Hybrid Signal | Buy |
| Risk Level | Medium |

The MRI of 0.80 indicates moderate investment risk. RSI at 63.88 suggests no clear sign of overbought or oversold. PPO at 0.39 also signals no strong signal of overbought or oversold. However, recent relative divergence improves, and the expected return is negative (-22.50%) compared to VOO.

**6. Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.71 (~Buy)
- Opinions: 20
- Target Price (avg/high/low): $116.80 / $160.00 / $70.00

**7. Recent News & Significant Events**

1. Raymond James Boosts Newmont (NEM) Target, Keeps Outperform Rating (link)
2. Is Newmont Stock Still a Buy After a 26% Rally in 3 Months? (Revised) (link)
3. The Goldman Sachs Group Issues Positive Forecast for Newmont (NYSE:NEM) Stock Price (link)
4. Why Newmont Corporation Stock Crashed Today (link)
5. Is NEM Stock Overvalued After A 135% Surge? (link)
6. Why Newmontâ€™s Feb. 19 results call matters to global investors everywhere (link)

**8. Recent Earnings Analysis**

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-23 | 1.67 | $5.52B |
| 2025-07-24 | 1.86 | $5.32B |
| 2025-04-24 | 1.68 | $5.01B |
| 2024-10-24 | 0.8 | $4.61B |
| 2025-10-23 | 0.8 | $4.61B |

The recent decline in the quarterly earnings per share (EPS) might affect the investor confidence in NEM.

**9. Financial Information**

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $5.52B | 53.04% |
| 2025-06-30 | $5.32B | 50.71% |
| 2025-03-31 | $5.01B | 46.13% |
| 2024-12-31 | $5.65B | 45.51% |
| 2024-09-30 | $4.61B | 36.13% |

The revenue shows slight increase from 2024-09-30 to recent quarters, and profit margin has a general uptrend.

### Capital and Profitability

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $33.23B | 5.51% |
| 2025-06-30 | $32.11B | 6.42% |
| 2025-03-31 | $31.25B | 6.05% |
| 2024-12-31 | $29.93B | 4.69% |
| 2024-09-30 | $29.71B | 3.10% |

Equity increases over time, and return on equity (ROE) has a general uptrend.

### Comprehensive Analysis

Newmont's cumulative return is higher compared to VOO, and Alpha and Beta analysis suggest average to above-average returns and relatively predictable movement. The MRI of 0.80 and RSI of 63.88 suggest moderate investment risk and no clear sign of overbought or oversold. However, the decline in the 5-day SMA and recent EPS drop might affect investor confidence. Overall, a comprehensive analysis of these factors suggests a moderate level of risk.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.